Skip to main content
Essay Undergraduate 4,142 words

Against Mandating COVID-19 Booster Shots for Children Under 18

~21 min read 7 sections Health · Health Policy
Abstract

This paper argues that the United States should not mandate COVID-19 booster shots for children aged 18 years and younger. Drawing on epidemiological data, comparative international policy, ethical frameworks including principlism and public health principles, and statements from leading health experts, the paper contends that healthy, fully vaccinated children are already well protected by two doses, that the available data does not support the added benefit of boosters for this population, and that the risk of adverse effects such as myocarditis outweighs any marginal gain. The paper also presents and rebuts the counterargument that boosters protect immunocompromised individuals by achieving herd immunity, concluding that resources would be better directed toward vaccinating unvaccinated, high-risk populations.

Key Takeaways
  • Introduction: Thesis statement against mandating boosters for children
  • Background: COVID-19 Risk in Children and Comparative Policy: Low pediatric risk and international policy comparison
  • Claim 1: Boosters Are Not Needed for Healthy, Fully Vaccinated Children: Two doses provide sufficient protection; ethical analysis
  • Claim 2: The Data Does Not Support Boosters for Children: Empirical evidence against boosters for this age group
  • Expert Opposition and Public Health Principles: Expert quotes and public health ethics framework
  • Counterargument and Rebuttal: Herd immunity argument presented and refuted
  • Conclusion: Summary of claims and restatement of thesis
✍️ How to write this paper — guide, tools & examples ▾

What makes this paper effective

  • The paper structures its argument systematically — presenting two independent affirmative claims, a counterargument, and a formal rebuttal — which creates a rigorous, debate-style logical progression.
  • It integrates multiple ethical frameworks (beneficence, nonmaleficence, autonomy, justice, solidarity, efficacy) alongside empirical data, demonstrating interdisciplinary reasoning rather than relying solely on statistics or solely on philosophy.
  • Direct quotations from credentialed authorities (WHO Chief Scientist, CDC Director, FDA advisory members) are used strategically to reinforce claims and lend institutional weight to the argument.

Key academic technique demonstrated

The paper demonstrates claim-counterclaim-rebuttal structure, a core technique in policy argumentation. By presenting the opposing view charitably — including its utilitarian philosophical grounding in Parfit's Principle of Group Beneficence — and then rebutting it with specific legal precedent (Jacobson v. Massachusetts) and real-world transmission data, the paper models how to engage opposing arguments rather than ignore them, strengthening overall persuasiveness.

Structure breakdown

The paper opens with an introduction stating its thesis, followed by a background section contextualizing COVID-19 risk in children and comparing international booster policies. Two affirmative claims are then developed — one grounded in medical necessity, one in empirical data — each supported by ethical frameworks. A section compiling expert opposition follows, after which the counterargument is presented and rebutted. The conclusion summarizes all supporting points and restates the thesis.

Essay 4,142 words

Introduction

The desire to develop and execute a vaccine to prevent infection with coronavirus disease 2019 (COVID-19) has been extraordinary. With the vaccine developed, the US government has put in place vaccine mandates to increase uptake among those who are eligible. However, the continued mutation of the virus has brought about the need for vaccine boosters to improve immunity across the population (Gostin, Salmon & Larson, 2021; World Health Organization [WHO], 2020). Intending to achieve herd immunity, health experts have also recommended the vaccination of children. Even though children are not at risk of being severely infected by COVID-19, they can still carry the disease. This has, however, raised the question of whether children aged 18 years and younger should be subject to a COVID-19 vaccine booster mandate.

This paper argues that the United States should not mandate COVID-19 booster shots for children 18 and younger. The discussion proceeds by presenting arguments supporting this proposition, presenting a claim against it, offering a rebuttal, and then concluding.

Background: COVID-19 Risk in Children and Comparative Policy

The US Food and Drug Administration (FDA) granted emergency use authorization for the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in children aged 5 to 11 years in October 2021 to reduce expensive hospitalizations. By that time, 1.8 million children in this age range had been diagnosed with SARS-CoV-2 infection, with 143 deaths and over 8,000 hospitalizations (Encinosa, Figueroa & Elias, 2022). By contrast, for the 2019–2020 influenza season, an estimated 35 million flu-related illnesses, 16 million flu-related medical visits, 380,000 flu-related hospitalizations, and 20,000 flu-related deaths were reported (CDC, 2021). Based on these figures, it is evident that influenza has a higher mortality rate among children, yet the flu shot is not mandatory.

COVID-19 has been reported in fewer young people than in adults in the United States and worldwide. Although children make up around 22% of the US population, they accounted for more than 17% of all COVID-19 cases reported to the Centers for Disease Control and Prevention (CDC) as of December 23, 2021 (CDC, 2022a). Most cases in children are mild, and supportive care is the most common treatment. In the debate over whether to institute booster mandates for children aged 18 and below, influenza offers useful comparative perspective. Both influenza and COVID-19 are contagious respiratory illnesses that affect the lungs and breathing and can be transmitted to others. COVID-19, however, appears to follow a milder clinical and laboratory course in children (Yılmaz et al., 2021).

Children without a serious medical condition have a very low risk of developing severe COVID-19 or long COVID. It is difficult to precisely measure that risk because it is so low, and it applies to both vaccinated and unvaccinated children (University College London, 2021). The reported number of COVID-19 hospitalizations for children in California — one of the major measures for assessing epidemic severity — was found to be dramatically overstated (Zweig, 2021a). This overstatement has distorted public perception of COVID-19's danger to children.

Compared to other countries' approaches to COVID-19 vaccination, the United States stands out as an exception, maintaining the strictest vaccination program for young people. Japan, Finland, Denmark, Norway, and several other countries have taken a more cautious approach to vaccines and boosters for children (Zweig, 2021b). Adult boosters are only required in Denmark, Sweden, and Japan. Some countries do not recommend COVID-19 vaccinations for healthy infants at all, or administer only one dose. A single dose is available for children aged 5 to 11, while a second dose is available for children aged 12 to 15. In Ireland, no one under the age of 16 is eligible for booster shots. In the United Kingdom, boosters are permitted only for teenagers aged 12 to 15 who are at very high risk.

Finally, according to the WHO, despite advances in vaccine production and research, the COVID-19 virus is likely to persist and circulate through society in a manner similar to influenza. This is significant because the Delta variant — a mutation of the original COVID-19 strain — was responsible for the bulk of new cases in the United States in mid and late 2021 (Kelley, 2021). Clinical evidence also shows that the protection provided by the Pfizer, Moderna, and Johnson & Johnson vaccines diminishes over time, which has been used to justify booster shots to prevent new infections.

5 Sections Hidden · 1,825 words
Claim 1: Boosters Are Not Needed for Healthy, Fully Vaccinated Children520 words
Children who have received two doses of a COVID-19 vaccine are well protected. Those who have been fully vaccinated are protected from serious illness,…
Claim 2: The Data Does Not Support Boosters for Children430 words
The evidence does not suggest that every fully vaccinated child needs a booster because protection against hospitalization and serious illness remains strong and long-lasting after the first two doses (Krause et al., 2021). Indeed, the push for boosters for young people may have the…
Expert Opposition and Public Health Principles360 words
Dr. Paul Offit, a member of the FDA's vaccine advisory group and…
Counterargument and Rebuttal340 words
The COVID-19 virus continues to spread in many communities even after vaccination. "Layers of protection" (Bhatt, 2021) are considered the best approach to…
Conclusion175 words
With the US government seeking to use all available tools to curb the spread of COVID-19 and reduce related hospitalizations, vaccine mandates represent one option. This paper has argued against mandating COVID-19 booster shots for children…
Key Concepts in This Paper
Booster Mandate Pediatric COVID-19 Vaccine Effectiveness Myocarditis Risk Herd Immunity Principlism Public Health Ethics Omicron Variant mRNA Vaccines Parental Autonomy
Cite This Paper
PaperDue. (2026). Against Mandating COVID-19 Booster Shots for Children Under 18. PaperDue. https://www.paperdue.com/study-guide/covid-19-booster-mandate-children-argument-2177446

Always verify citation format against your institution’s current style guide requirements.